These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17239692)

  • 21. Utility of the fractional flow reserve in the evaluation of angiographically moderate in-stent restenosis.
    Lopez-Palop R; Pinar E; Lozano I; Saura D; Picó F; Valdés M
    Eur Heart J; 2004 Nov; 25(22):2040-7. PubMed ID: 15541841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional result following direct coronary artery stenting with drug eluting stents in chronic stable angina is similar to stenting after balloon predilatation.
    Balachandran KP; Singh B; Sandilands A; Popusoi G; Rubino P; Baumbach A
    Int J Cardiol; 2008 Aug; 128(3):374-7. PubMed ID: 17689737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
    Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ;
    Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective registry evaluating safety and efficacy of cobalt-chromium stent implantation in patients with de novo coronary lesions.
    Buszman P; Trznadel S; Zurakowski A; Milewski K; Kinasz L; Król M; Kondys M
    Kardiol Pol; 2007 Sep; 65(9):1041-6; discussion 1047-8. PubMed ID: 17975751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease.
    Yang ZK; Shen WF; Zhang RY; Kong Y; Zhang JS; Hu J; Zhang Q; Ding FH
    J Interv Cardiol; 2007 Feb; 20(1):10-6. PubMed ID: 17300391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians.
    Rodés-Cabau J; Deblois J; Bertrand OF; Mohammadi S; Courtis J; Larose E; Dagenais F; Déry JP; Mathieu P; Rousseau M; Barbeau G; Baillot R; Gleeton O; Perron J; Nguyen CM; Roy L; Doyle D; De Larochellière R; Bogaty P; Voisine P
    Circulation; 2008 Dec; 118(23):2374-81. PubMed ID: 19029471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PCI versus CABG for multivessel coronary disease in diabetics.
    Tarantini G; Ramondo A; Napodano M; Favaretto E; Gardin A; Bilato C; Nesseris G; Tarzia V; Cademartiri F; Gerosa G; Iliceto S
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):50-8. PubMed ID: 19089938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The reliability of fractional flow reserve measurement in patients with diabetes mellitus.
    Sahinarslan A; Kocaman SA; Olgun H; Kunak T; Kiziltunç E; Ozdemir M; Timurkaynak T
    Coron Artery Dis; 2009 Aug; 20(5):317-21. PubMed ID: 19444091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel coronary artery disease: results from the Intermountain Heart Registry.
    Bair TL; Muhlestein JB; May HT; Meredith KG; Horne BD; Pearson RR; Li Q; Jensen KR; Anderson JL; Lappé DL
    Circulation; 2007 Sep; 116(11 Suppl):I226-31. PubMed ID: 17846308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
    Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
    J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monocyte toll-like receptor 2 and 4 responses and expression following percutaneous coronary intervention: association with lesion stenosis and fractional flow reserve.
    Versteeg D; Hoefer IE; Schoneveld AH; de Kleijn DP; Busser E; Strijder C; Emons M; Stella PR; Doevendans PA; Pasterkamp G
    Heart; 2008 Jun; 94(6):770-6. PubMed ID: 17686802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial.
    van Nunen LX; Zimmermann FM; Tonino PA; Barbato E; Baumbach A; Engstrøm T; Klauss V; MacCarthy PA; Manoharan G; Oldroyd KG; Ver Lee PN; Van't Veer M; Fearon WF; De Bruyne B; Pijls NH;
    Lancet; 2015 Nov; 386(10006):1853-60. PubMed ID: 26333474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fractional flow reserve compared with intravascular ultrasound guidance for optimizing stent deployment.
    Fearon WF; Luna J; Samady H; Powers ER; Feldman T; Dib N; Tuzcu EM; Cleman MW; Chou TM; Cohen DJ; Ragosta M; Takagi A; Jeremias A; Fitzgerald PJ; Yeung AC; Kern MJ; Yock PG
    Circulation; 2001 Oct; 104(16):1917-22. PubMed ID: 11602494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
    Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents.
    Freeman M; Clark DJ; Andrianopoulos N; Duffy SJ; Lim HS; Brennan A; Charter K; Shaw J; Horrigan M; Ajani AE; Sebastian M; Reid CM; Farouque HM;
    Catheter Cardiovasc Interv; 2009 May; 73(6):763-8. PubMed ID: 19309731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute coronary syndrome is an independent risk factor for late incomplete stent apposition after sirolimus-eluting stent implantation.
    Zhang RY; DU R; Zhu ZB; Zhang Q; Hu J; Lü AK; Zhang JS; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(24):2504-8. PubMed ID: 19187586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI).
    Morrison DA; Berman M; El-Amin O; McLaughlin RT; Bates ER
    Minerva Cardioangiol; 2007 Oct; 55(5):593-623. PubMed ID: 17912165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in the outcomes of percutaneous coronary intervention with the routine incorporation of fractional flow reserve in real practice.
    Park SJ; Ahn JM; Park GM; Cho YR; Lee JY; Kim WJ; Han S; Kang SJ; Park DW; Lee SW; Kim YH; Lee CW; Mintz GS; Park SW
    Eur Heart J; 2013 Nov; 34(43):3353-61. PubMed ID: 24092248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses.
    Barbato E; Bartunek J; Aarnoudse W; Vanderheyden M; Staelens F; Wijns W; Heyndrickx GR; Pijls NH; De Bruyne B
    Eur Heart J; 2004 Nov; 25(22):2034-9. PubMed ID: 15541840
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.